Trial intelligence / Profile preview

Divalproex Sodium Adjunctive to Stimulants for Aggressive Children With ADHD

NCT00228046Phase 4Completed

Sponsor
Stony Brook University
Start
Jan 2004
Primary completion
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of divalproex sodium in attention deficit hyperactivity disorder (ADHD), conduct disorder (CD), oppositional defiant disorder (ODD), sponsored by Stony Brook University. Started Jan 2004; status: completed.

02

Drugs

divalproex sodium
03

Conditions

attention deficit hyperactivity disorder (ADHD)conduct disorder (CD)oppositional defiant disorder (ODD)

Beyond the preview

Go deeper on NCT00228046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00228046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call